Saturday, July 4, 2026 Live from SEC EDGAR

The Wire Leaderboards Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

GSK — GSK plc SEC Filings | FilingIndex

GSKNYSE

GSK plc

Pharmaceutical Preparations · X0 · CIK 1131399

Develops and manufactures innovative medicines and vaccines

+ Watch View on EDGAR ↗

$107.47B

Market cap

$53.66

Last close

+4.6%

1D

+3.4%

5D

3.8M

Volume

Price$53.66+39.3%· 1Y

Jul 2L $36.20 · H $61.18Jul 2

927

Total filings

Jun 29, 2026

Last filing

—

Fiscal year end

All 6-K · 909 11-K · 10 20-F · 4 SC 13G · 2 SC 13D · 2 SC 13D/A · 1

6-KTRANSACTION IN OWN SHARESJun 29, 2026 6-KHOLDING(S) IN COMPANYJun 29, 2026 6-KHOLDING(S) IN COMPANYJun 26, 2026 6-KDIRECTOR/PDMR SHAREHOLDINGJun 24, 2026 6-KGSK ANNOUNCES TENDER OFFER TO ACQUIRE NUVALENTJun 24, 2026 6-K

Similar companies

Comparable business profile · signals at a glance

SHELShell plc$216.2B+1.9%BCSBARCLAYS PLC$93.6B+1.8%NWGNatWest Group plc$71.6B0.0%ULUNILEVER PLC$134.5B+2.6%HLNHaleon plc$43.2B

DIRECTOR/PDMR SHAREHOLDING

Jun 23, 2026

6-KTRANSACTION IN OWN SHARESJun 22, 2026

11-K11-KJun 17, 2026

11-K11-KJun 17, 2026

6-KCUTI ORAL ANTIBIOTIC TEBIPENEM APPROVED BY US FDAJun 17, 2026

6-KTRANSACTION IN OWN SHARESJun 15, 2026

6-KMOMELOTINIB ORPHAN DRUG DESIGNATIONS FOR VEXASJun 12, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGJun 11, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGJun 10, 2026

6-KDR HAL BARRON - NEW DIRECTORSHIPJun 9, 2026

6-KGSK ENTERS AGREEMENT TO ACQUIRE NUVALENT, INC.Jun 9, 2026

6-KTRANSACTION IN OWN SHARESJun 8, 2026

6-KTOTAL VOTING RIGHTSJun 1, 2026

6-KTRANSACTION IN OWN SHARESJun 1, 2026

6-KPOSITIVE PHASE 3 DATA FOR BEPIROVIRSENMay 28, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGMay 27, 2026

6-KADMISSION TO TRADINGMay 26, 2026

6-KTRANSACTION IN OWN SHARESMay 26, 2026

6-KQ2 2026 RESULTS DATE CONFIRMED - 28 JULY 2026May 22, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGMay 20, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGMay 20, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGMay 19, 2026

6-KTRANSACTION IN OWN SHARESMay 18, 2026

6-KJAPAN MHLW APPROVES AREXVY FOR ADULTS 18-49 AIRMay 18, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGMay 14, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGMay 11, 2026

6-KCOLLABORATION WITH CTTQ FOR BEPIROVIRSENMay 11, 2026

6-KGSK - FINAL TRANCHE OF SHARE BUYBACK PROGRAMMEMay 11, 2026

6-KRESULT OF AGMMay 6, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGMay 5, 2026

6-KTOTAL VOTING RIGHTSMay 1, 2026

6-KHOLDING(S) IN COMPANYMay 1, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGApr 29, 2026

6-K1ST QUARTER RESULTSApr 29, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGApr 28, 2026

6-KBEPIROVIRSEN PRIORITY REVIEW US FILING ACCEPTANCEApr 28, 2026

6-KEFIMOSFERMIN GRANTED US/EU REGULATORY DESIGNATIONSApr 27, 2026

6-KTESARO UPDATE ON ANAPTYSBIO INC. LITIGATIONApr 27, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGApr 24, 2026

6-KTRANSACTION IN OWN SHARESApr 23, 2026

6-KTRANSACTION IN OWN SHARESApr 22, 2026

6-KTRANSACTION IN OWN SHARESApr 21, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGApr 20, 2026

6-KBLENREP APPROVED IN CHINA FOR 2L+ MULTIPLE MYELOMAApr 20, 2026

6-KTRANSACTION IN OWN SHARESApr 20, 2026

6-KTRANSACTION IN OWN SHARESApr 17, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGApr 16, 2026

6-KTRANSACTION IN OWN SHARESApr 16, 2026

6-KGSK COMPLETES ACQUISITION OF 35PHARMA INC.Apr 15, 2026

6-KTRANSACTION IN OWN SHARESApr 15, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGApr 14, 2026

6-KTRANSACTION IN OWN SHARESApr 14, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGApr 13, 2026

6-KGSK PRESENTS POSITIVE DATA FOR BEHOLD 1 B7 H4 ADCApr 13, 2026

6-KTRANSACTION IN OWN SHARESApr 13, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGApr 10, 2026

6-KTRANSACTION IN OWN SHARESApr 10, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGApr 9, 2026

6-KTRANSACTION IN OWN SHARESApr 9, 2026

6-KEXDENSUR APPROVED FOR CRSWNP IN CHINAApr 8, 2026

6-KTRANSACTION IN OWN SHARESApr 8, 2026

6-KTRANSACTION IN OWN SHARESApr 7, 2026

6-KTRANSACTION IN OWN SHARESApr 2, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGApr 1, 2026

6-KTOTAL VOTING RIGHTSApr 1, 2026

6-KTRANSACTION IN OWN SHARESApr 1, 2026

6-KVIIV COMPLETES CHANGES TO MINORITY SHAREHOLDINGApr 1, 2026

6-KTRANSACTION IN OWN SHARESMar 31, 2026

6-KBEPIROVIRSEN ACCEPTED FOR REVIEW IN CHINAMar 30, 2026

6-KEXDENSUR APPROVED FOR SEVERE ASTHMA IN CHINAMar 30, 2026

6-KTRANSACTION IN OWN SHARESMar 30, 2026

6-KTRANSACTION IN OWN SHARESMar 27, 2026

6-KBEPIROVIRSEN ACCEPTED FOR REVIEW BY THE EMAMar 27, 2026

6-KTRANSACTION IN OWN SHARESMar 26, 2026

6-KDIRECTOR/PDMR SHAREHOLDINGMar 25, 2026

+4.5%

RELXRELX PLC$55.9B+1.8%